文献速递外周动脉疾病

临床衰弱评分、CT衍生体成分、全身炎症与慢性肢体威胁性缺血患者生存的关系

The Relationship between Clinical Frailty Score, CT-Derived Body Composition, Systemic Inflammation, and Survival in Patients with Chronic Limb-Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2023-06-24

本研究连续纳入12个月内单一三级中心非计划入院的190例慢性肢体威胁性缺血患者,用临床衰弱量表评估衰弱、L3水平CT评估体成分、改良格拉斯哥预后评分评估炎症。中位随访22个月(范围15-32个月)期间79例死亡。CFS>4、CT-SS和mGPS均独立与死亡率升高相关;CT-SS0且CFS≤4者1年生存率90%,CT-SS2且CFS>4者仅35%。

要点

  • CFS>4、CT-SS和mGPS均独立与慢性肢体威胁性缺血患者死亡率升高相关。
  • CT-SS0且CFS≤4者1年生存率90%,CT-SS2且CFS>4者35%。
  • mGPS0且CFS≤4者1年生存率94%,mGPS2且CFS>4者44%。

核心结论

  • CFS评估的衰弱与CT体成分相关,CFS、CT-SS和mGPS与非计划入院的慢性肢体威胁性缺血患者较差的生存相关。
  • 作者认为CT-SS和mGPS可能部分有助于该患者队列的衰弱和预后评估。

研究设计与样本

  • 连续纳入12个月期间单一三级中心非计划入院的慢性肢体威胁性缺血患者,共190例。
  • 衰弱用临床衰弱量表诊断,体成分用L3椎体水平CT评估生成内脏脂肪指数、皮下脂肪指数、骨骼肌指数和骨骼肌密度,骨骼肌指数与密度组合为CT-肌少症评分,全身炎症用改良格拉斯哥预后评分评估。
  • 主要结局为总死亡率,中位随访22个月(四分位距6个月,范围15-32个月)。

主要发现

  • 随访期间79例死亡,100例(53%)CFS>4。
  • CFS>4(HR 2.14,95%CI 1.25-3.66,P<0.01)、CT-SS(HR 1.47,95%CI 1.03-2.09,P<0.05)和mGPS(HR 1.54,95%CI 1.11-2.13,P<0.01)独立与死亡率升高相关。
  • CT-SS(OR 1.88,95%CI 1.09-3.24,P<0.01)独立与CFS>4相关。
  • CT-SS 0且CFS≤4者1年生存率90%(SE 5%),CT-SS 2且CFS>4者为35%(SE 9%)(P<0.001)。
  • mGPS 0且CFS≤4者1年生存率94%(SE 4%),mGPS 2且CFS>4者为44%(SE 6%)(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is a chronic condition with complex etiology and impaired functional performance that has been associated with altered body composition and chronic inflammation. Chronic limb-threatening ischemia (CLTI) carries significant morbidity and mortality and is associated with poor quality of life. The present study aims to examine these relationships and their prognostic value in patients with CLTI. METHODS: Consecutive patients presenting as unscheduled admissions to a single tertiary center with CLTI were included over a 12-month period. Frailty was diagnosed using the Clinical Frailty Scale (CFS). Body composition was assessed using computerised tomography (CT) at the L3 vertebral level (CT-BC) to generate visceral and subcutaneous fat indices, skeletal muscle index, and skeletal muscle density. Skeletal muscle index and skeletal muscle density were combined to form the CT-sarcopenia score (CT-SS). Systemic inflammation was assessed by the modified Glasgow prognostic score (mGPS). The primary outcome was overall mortality. RESULTS: There were 190 patients included with a median (interquartile range) follow-up of 22 (6) months (range 15-32 months) and 79 deaths during the follow-up period. One hundred patients (53%) had a CFS >4. CFS >4 (hazard ratio [HR] 2.14, 95% confidence interval [CI] 1.25-3.66, P < 0.01), CT-SS (HR 1.47, 95% CI 1.03-2.09, P < 0.05), and mGPS (HR 1.54, 95% CI 1.11-2.13, P < 0.01) were independently associated with increased mortality. CT-SS (odds ratio 1.88, 95% CI 1.09-3.24, P < 0.01) was independently associated with CFS >4. Patients with CT-SS 0 and CFS ≤4 had 90% (standard error [SE] 5%) 1-year survival, compared with 35% (SE 9%) in patients with CT-SS 2 and CFS >4 (P < 0.001). Patients with mGPS 0 and CFS ≤4 had 94% (SE 4%) 1-year survival compared with 44% (SE 6%) in the mGPS 2 and CFS >4 subgroup (P < 0.001). CONCLUSIONS: Frailty assessed by CFS was associated with CT-BC. CFS, CT-SS, and mGPS were associated with poorer survival in patients presenting as unscheduled admissions with CLTI. CT-SS and mGPS may contribute to part of frailty and prognostic assessment in this patient cohort.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bradley NA, Walter A, Roxburgh CSD, et al. The Relationship between Clinical Frailty Score, CT-Derived Body Composition, Systemic Inflammation, and Survival in Patients with Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2023. PMID: 37356659. doi:10.1016/j.avsg.2023.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。